PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding PDS Biotechnology Corp changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 41 | 52 | +11 |
| Shares | 5.05M | 7.69M | +2.64M (+52.4%) |
| Value | $3.05M | $6.78M | +$3.72M (+121.9%) |
New holders (15)
Institutions that held PDS Biotechnology Corp at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colony Group, LLC | 642,177 | $565.8K | 0.00% |
| Quantinno Capital Management LP | 642,177 | $565.8K | 0.00% |
| Militia Capital Management LLC | 331,800 | $292.3K | 0.05% |
| Citadel Advisors LLC | 323,801 | $285.3K | 0.00% |
| Jane Street Group, LLC | 279,664 | $246.4K | 0.00% |
| Marshall Wace, LLP | 147,171 | $129.5K | 0.00% |
| Advisor Group Holdings, Inc. | 30,000 | $26.4K | 0.00% |
| The PNC Financial Services Group, Inc. | 11,900 | $10.5K | 0.00% |
| SG Americas Securities, LLC | 10,367 | $9.00K | 0.00% |
| Goldman Sachs Group Inc | 10,048 | $8.85K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,942 | $3.47K | 0.00% |
| Rialto Wealth Management, LLC | 761 | $671 | 0.00% |
| Barclays PLC | 582 | $513 | 0.00% |
| Markowski Investments | 500 | $441 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held PDS Biotechnology Corp at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Armistice Capital, LLC | 173,605 | $105.0K |
| Nine Masts Capital Ltd | 67,507 | $40.8K |
| Wealth Group, Ltd. | 13,399 | $8.00K |
| Simplex Trading, LLC | 271 | $163 |